DocGo Wins 'Compliance Management Innovation Award' in 2025 MedTech Breakthrough Awards Program
DocGo's breakthrough Compliance Program excels at adapting to the organization's dynamic environment and consistently updating its strategies to address emerging risks and technologies. The program's approach focuses on managing ethics, compliance, and risk management to strengthen corporate culture, drive results, and promote transparency and accountability within the healthcare industry.
DocGo's Compliance Program ensures alignment with industry standards and federal and state regulations, even as the organization scales rapidly and introduces innovative solutions to the healthcare industry. The program's annual compliance survey, a key component, provides employees with an additional confidential channel to report concerns and share feedback.
'Our Compliance Program has been an essential component in the success of our organization, and is built on the foundation of organizational excellence. Along with transparency and ethical practices, our approach remains focused on fostering a culture of trust,' said Stephen Sugrue, DocGo's Chief Compliance Officer. 'We're grateful to MedTech Breakthrough for this recognition, and we remain committed to delivering high quality, highly accessible healthcare to all, and through our meticulously crafted Compliance Program, to do so ethically.'
The MedTech Breakthrough Awards program celebrates excellence and innovation in the health and medical technology industry, recognizing the companies, products, and solutions driving meaningful progress and improving patient care. Spanning a wide range of categories—including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and beyond—the awards highlight the groundbreaking work that is transforming the healthcare landscape.
This year's program saw a record-breaking number of nominations from leading companies and startups across more than 18 countries, showcasing the global impact and momentum of the digital healthcare industry today.
'DocGo's approach to compliance offers innovative strategies to consistently build a strong foundation. Healthcare organizations need to implement and streamline policies and procedures that address emerging issues and ensure compliance with regulatory standards. From patient safety to care quality, to employee satisfaction, the right policies build trust and reputation,' said Steve Johansson, managing director, MedTech Breakthrough. 'DocGo's Compliance Program has all the hallmarks of a well-designed program with ample resources, empowerment, and the evidence of working incredibly well in practice. We're thrilled to award them our 2025 'Compliance Management Innovation Award!''
By incorporating the Department of Justice (DOJ) 2024 Evaluation of Corporate Compliance Programs, DocGo's program has been able to further improve its effectiveness strategies. This guidance has been the model framework in building the 2025 Compliance & Audit Work Plan, a valuable resource that assesses the program based on the DOJ's risk strategy initiatives. The work plan has been enhanced with various risk assessments conducted by key stakeholders, as well as incorporating and handling risks with new and emerging technology, and streamlining cybersecurity procedures to improve HIPAA privacy objectives.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and medical transport solutions. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com. To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit www.proactivecarenow.com.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 minutes ago
- Business Wire
Toshiba Releases Lens-Reduction Type CCD Linear Image Sensor with Low Random Noise That Helps Improve Image Quality in Devices Such as A3 Multifunction Printers
KAWASAKI, Japan--(BUSINESS WIRE)-- Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched a lens-reduction type [1] CCD [2] linear image sensor ' TCD2728DG ' for A3 multifunction printers. Shipments start today. The sensor has 7,500 image sensing elements (pixels) [3] and supports A3 multifunction printers. It is also more effective at reducing random noise (NDσ) [4] than Toshiba's current TCD2726DG. Business offices are seeing a growing need for high-speed, high-resolution copying and scanning of large volumes of different kinds of documents. This is particularly true for A3 multifunction printers, where improving image quality has become an important issue, and NDσ in the signal has to be suppressed to enhance image quality. TCD2728DG has lower output amplifier gain [5] than Toshiba's current product, TCD2726DG, and reduces NDσ by approximately 40% [6]. This improvement enhances image quality in multifunction printers. The new CCD linear sensor achieves a data rate of 100 MHz (50 MHz × 2 channels), enabling high-speed processing of large volumes of images. This makes it well-suited for line scan cameras used in inspection systems that require real-time decision-making. Toshiba will continue to expand its product lineup to support scanning by multifunction printers and the sensing applications of inspection devices, and to meet growing demand for high-speed, high-resolution imaging and sensing technologies. Notes: [1] The method of reducing an image with optical lenses and projecting it onto a CCD or CMOS image sensor. [2] CCD: Charge Coupled Device [3] Number of pixels required to scan the short side (297 mm) of A3 size at a resolution of 600 dpi. (dpi (dots per inch): number of divisions per inch) A3 size converted to inches: 297 mm / 25.4 mm ≒ 11.7 inches 11.7 × 600 = 7,020 pixels --> Allowing for margin, 7,500 pixels [4] Irregular noise that affects the quality of the image. [5] A circuit to adjust the amplification of the output signal. Amplification and noise are proportional. [6] Comparison with Toshiba's current product TCD2726DG. Values measured by Toshiba. Expand Applications A3 multifunction printers (resolution of 600 dpi) 7500-pixel line scan camera for various inspection systems (semiconductor inspection equipment, food sorting equipment, etc.) Features Reduces random noise by approximately 40% [6] High-speed CCD linear image sensor: Data rate =100MHz (Master clock frequency 50MHz × 2ch) (max) The built-in timing generator circuit [7] and CCD driver help facilitate system development [7] Circuit for generating signals necessary to drive a linear image sensor. Expand Main Specifications (Ta=25°C) Part number TCD2728DG Power supply voltage (operating range) (V) V AVDD, V DVDD, V CKDVDD: 3.1 to 3.5 V VDD10: 9.5 to 10.5 Random noise NDσ (mV) 1.9 Pixel size (μm) 4.7 × 4.7 Number of image sensing elements 7500 elements × 3 lines Data rate Max 100MHz (50MHz × 2ch) Package WDIP32 Others / Additional features Timing generator circuit, CCD driver Expand Follow the link below for more on the new product. TCD2728DG Follow the link below for more on Toshiba's linear image sensors. Linear Image Sensors * Company names, product names, and service names may be trademarks of their respective companies. * Information in this document, including product prices and specifications, content of services and contact information, is current on the date of the announcement but is subject to change without prior notice. About Toshiba Electronic Devices & Storage Corporation Toshiba Electronic Devices & Storage Corporation, a leading supplier of advanced semiconductor and storage solutions, draws on over half a century of experience and innovation to offer customers and business partners outstanding discrete semiconductors, system LSIs and HDD products. Its 19,400 employees around the world share a determination to maximize product value, and to promote close collaboration with customers in the co-creation of value and new markets. The company looks forward to building and to contributing to a better future for people everywhere. Find out more at
Business Wire
32 minutes ago
- Business Wire
AGL Investors Have Opportunity to Join agilon health, inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of agilon health, inc. ('Agilon' or 'the Company') (NYSE: AGL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Agilon announced on August 4, 2025, that President and CEO Steven Sell was stepping down immediately. The Company also withdrew its full-year 2025 financial guidance. Based on this news, shares of Agilon fell by more than 27.2% in after hours trading on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Yahoo
an hour ago
- Yahoo
Should You Buy Nvidia Stock Before Aug. 27? Here's What the Evidence Suggests.
Key Points After more than two years of phenomenal gains, investors are wary about the future of AI. Nvidia's GPUs are a staple in the AI revolution, and sales continue at a brisk pace. There's a growing body of evidence that suggests Nvidia's epic run will continue, as will the stocks volatility. 10 stocks we like better than Nvidia › The dawn of artificial intelligence (AI) in late 2022 has had a profound impact on the technology landscape. The initial fervor has since died down, and investors are looking for compelling evidence that the adoption of AI has room to run. Nvidia (NASDAQ: NVDA) graphics processing units (GPUs) were widely adopted and have become the gold standard for generative AI. The company is scheduled to release the results of its fiscal 2026 second quarter after the market closes on Wednesday, Aug. 27, and Wall Street and shareholders alike will be sitting on the edge of their seats looking for clues that strong demand for AI chips continues. Let's look at the company's most recent results, what current events suggest about the future, and determine if Nvidia stock still represents a compelling opportunity heading into the company's highly anticipated financial report. Remarkable results After generating triple-digit revenue and profit growth for two consecutive fiscal years, growth inevitably slowed, and investors got the jitters. Despite tough year-over-year comps, Nvidia's results were still enviable. For its fiscal 2026 first quarter (ended April 27), Nvidia reported record revenue of $44.1 billion, which soared 69% year over year and 12% sequentially. This resulted in adjusted earnings per share (EPS) of $0.81, up 33%, but there's an asterisk on those numbers. Nvidia took a $4.5 billion writedown on H20 chips destined for China, because of the Trump administration's moratorium on AI chip sales in that country (which has since been lifted). Without that charge, EPS would have been $0.96, a 57% increase. Make no mistake: It was the continuing adoption of AI that drove the robust results, as revenue from Nvidia's data center segment climbed 73% to $39 billion, representing 89% of its total revenue. Management expects Nvidia's growth spurt to continue, albeit at a more moderate pace. For its fiscal 2026 second quarter (ended July 27), management is guiding for revenue of $45 billion, which would represent year-over-year growth of 50%. Wall Street is equally bullish, with analysts' consensus estimates calling for revenue of $45.68 billion and adjusted EPS of $1.00. While this would represent a minor slowing compared with last quarter's robust growth, it would still be remarkable nonetheless. Same customers, expanding opportunity The biggest concern among Nvidia investors is that the adoption of AI will hit a wall, but there's simply no evidence to back that assertion. In fact, all the available evidence suggests the proliferation of AI continues. Amazon Web Services, Microsoft Azure, and Alphabet's Google Cloud, are collectively known as the "Big Three" in cloud computing, and each has recently revealed plans to increase infrastructure spending this year, beyond the already robust spending that was previously announced. Furthermore, most of that spending will be allocated to additional data centers to support the growing demand for AI -- most of which will run on Nvidia GPUs. In addition, Meta Platforms also announced that it was increasing its capital expenditure spending plans for the year. The totals are enlightening: Amazon: $118 billion, up from $100 billion. Microsoft: $100 billion, up from $80 billion. Alphabet: $85 billion, up from $75 billion. Meta: $69 billion, up from $62.5 It's no coincidence that these four companies are also Nvidia's biggest customers. Add to that the resumption of H20 chip sales and China, and it appears clear that Nvidia's AI opportunity continues to expand. Should you buy the stock before Aug. 27? To be clear, I expect Nvidia stock to remain volatile, driven by the inevitable ebbs and flows of AI spending. That said, its success thus far has been undeniable. Over the past three years, the stock has gained 882% (as of this writing) but has also fallen as much as 37% -- so it isn't for the faint of heart. This helps illustrate one of the hallmarks of investing success: Treat buying stocks as partial ownership in a business, own stocks in the best companies out there, and commit to holding for at least three to five years. That takes us back to the main question: Should you buy Nvidia stock before Aug. 27? The unspoken question here is whether Nvidia stock will be up or down following the release of its highly anticipated quarterly report. Truth be told, I have no idea, nor does anyone else for that matter. My crystal ball has been on the blink for some time, but if I were in the mood to prognosticate, I would feel comfortable making several very vague predictions: Nvidia will announce yet another in a long and growing series of quarterly revenue records. Given the company's track record of exceeding expectations, I suspect it will beat analysts' consensus estimates, which are calling for sales of $45.68 billion -- which is slightly ahead of management's guidance of $45 billion -- and adjusted EPS of $1.00. Beyond that, it's anyone's guess, and my predictions could be way off base. That said, I'm still extremely confident that my investing thesis for Nvidia remains intact. The company's cutting-edge GPUs are still the gold standard, driving the AI revolution, and rivals have yet to challenge its position as the undisputed market leader or come up with a superior product. The specter of competition remains, as there's always the possibility that a technological innovation could steal Nvidia's thunder. Most experts agree that it's still early innings for AI, but there's no consensus about the size of the market. Even the most conservative estimates start at $1 trillion. Big Four accounting firm PwC estimates the total economic impact at $15.7 trillion between now and 2030. The truth is nobody knows for sure. Nvidia stock is currently selling for roughly 30 times next year's earnings. However, that premium is backed by the company's track record of innovation, industry-leading position, and history of growth. This underpins my confidence that the runway ahead is long. For those who believe that the AI revolution will play out over the next decade and Nvidia will maintain its position as the leading provider of AI chips, the answer is clear. We don't know what the stock will do between now and Aug. 27 and for long-term investors, that doesn't matter. We'll simply buckle up for the bumpy (and profitable) ride ahead. Do the experts think Nvidia is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Nvidia make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Danny Vena has positions in Alphabet, Amazon, Meta Platforms, Microsoft, and Nvidia. The Motley Fool has positions in and recommends Alphabet, Amazon, Meta Platforms, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Should You Buy Nvidia Stock Before Aug. 27? Here's What the Evidence Suggests. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
